Literature DB >> 15637037

Serum sickness associated with rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia.

M Catuogno, S Rezai, R Priori, L Magrini, G Valesini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15637037     DOI： 10.1093/rheumatology/keh470

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

1.  Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome.

Authors:  Raphaèle Seror; Christelle Sordet; Loic Guillevin; Eric Hachulla; Charles Masson; Marc Ittah; Sophie Candon; Véronique Le Guern; Achille Aouba; Jean Sibilia; Jacques-Eric Gottenberg; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2006-09-01       Impact factor: 19.103

Review 2.  Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature.

Authors:  Freke Wink; Pieternella M Houtman; Tim L Th A Jansen
Journal:  Clin Rheumatol       Date:  2010-10-31       Impact factor: 3.650

3.  Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura.

Authors:  Shoko Goto; Hiroaki Goto; Reo Tanoshima; Hiromi Kato; Hiroyuki Takahashi; Osamu Sekiguchi; Sumio Kai
Journal:  Int J Hematol       Date:  2009-03-24       Impact factor: 2.319

Review 4.  Novel applications of Rituximab in dermatological disorders.

Authors:  Prasan R Bhandari; Varadraj V Pai
Journal:  Indian Dermatol Online J       Date:  2014-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.